Abstract:We demonstrate that Mycobacterium tuberculosis recombinant leucine-responsive regulatory protein (rLrp) inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF-α), interleukin-6, and interleukin-12 production and blocks the nuclear translocation of subunits of the nuclear-receptor transcription factor NF-κB (Nuclear factor-kappa B). Moreover, rLrp attenuated LPS-induced DNA binding and NF-κB transcriptional activity, which was accompanied by the degradation of inhibitory IκBα and a consequent decrease in the nuclear translocation of the NF-κB p65 subunit. RLrp interfered with the LPS-induced clustering of TNF receptor-associated factor 6 and with interleukin-1 receptor-associated kinase 1 binding to TAK1. Furthermore, rLrp did not attenuate proinflammatory cytokines or the expression of CD86 and major histocompatibility complex class-II induced by interferon-gamma in the macrophages of Toll-like receptor 2 deletion (TLR2 −/− ) mice and in protein kinase b (Akt)-depleted mouse cells, indicating that the inhibitory effects of rLrp were dependent on TLR2-mediated activation of the phosphatidylinositol 3-OH kinase (PI3K)/Akt pathway. RLrp could also activate the PI3K/Akt pathway by stimulating the rapid phosphorylation of PI3K, Akt, and glycogen synthase kinase 3 beta in macrophages. In addition, 19 amino acid residues in the N-terminus of rLrp were determined to be important and required for the inhibitory effects mediated by TLR2. The inhibitory function of these 19 amino acids of rLrp raises the possibility that mimetic inhibitory peptides could be used to restrict innate immune responses in situations in which prolonged TLR signaling has deleterious effects. Our study offers new insight into the inhibitory mechanisms by which the TLR2-mediated PI3K/Akt pathway ensures the transient expression of potent inflammatory mediators.

RP105 Involved in Activation of Mouse Macrophages Via TLR2 and TLR4 Signaling

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Activation of the RON Receptor Tyrosine Kinase Protects Murine Macrophages from Apoptotic Death Induced by Bacterial Lipopolysaccharide.

Involvement Of Rp105 And Toll-Like Receptors In The Activation Of Mouse Peritoneal Macrophages By Staphylococcus Aureus

The Rlrp of Mycobacterium Tuberculosis Inhibits Proinflammatory Cytokine Production and Downregulates APC Function in Mouse Macrophages Via a TLR2-mediated PI3K/Akt Pathway Activation-Dependent Mechanism

The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes

Disabled-2 negatively regulates lipopolysaccharide-stimulated Toll-like receptor 4 signaling and inflammation response in murine macrophage (INM7P.349)

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

LNCGM1082 -Mediated NLRC4 Activation Drives Resistance to Bacterial Infection

Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells

Ras-Related Protein Rab10 Facilitates Tlr4 Signaling By Promoting Replenishment Of Tlr4 Onto The Plasma Membrane

Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages

Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathways

Inactivation of TMEM106A Promotes Lipopolysaccharide-Induced Inflammation Via the MAPK and NF-κB Signaling Pathways in Macrophages.

LncRNA LNCGM1082-mediated NLRC4 activation resists against infection by intracellular bacteria

Analysis of Tlr4-Mediated LPS Signal Transduction in Macrophages by Mutational Modification of the Receptor

MAPK/p38 regulation of cytoskeleton rearrangement accelerates induction of macrophage activation by TLR4, but not TLR3

Epigenetically modulated LRRC33 acts as a negative physiological regulator for multiple Toll-like receptors.

NLRC4 Activation Needs Lncrna LNCGM1082

Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.

The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.